Cargando…
Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
BACKGROUND: The reversibility of pulmonary arterial hypertension (PAH) in congenital heart disease (CHD) is of great importance for the operability of CHD. Proteomics analysis found that transgelin was significantly up‐regulated in the lung tissue of CHD‐PAH patients, especially in the irreversible...
Autores principales: | Huang, Li, Li, Li, Yang, Tao, Li, Wen, Song, Li, Meng, Xianmin, Gu, Qing, Xiong, Changming, He, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237561/ https://www.ncbi.nlm.nih.gov/pubmed/30338626 http://dx.doi.org/10.1111/jcmm.13912 |
Ejemplares similares
-
Potential biomarkers and targets in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study
por: Huang, Li, et al.
Publicado: (2018) -
Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt‐related pulmonary arterial hypertension
por: Zhou, Jing‐jing, et al.
Publicado: (2022) -
The expression of survivin in irreversible pulmonary arterial
hypertension rats and its value in evaluating the reversibility of pulmonary
arterial hypertension secondary to congenital heart disease
por: Li, Gang, et al.
Publicado: (2019) -
Incorporation of noninvasive assessments in risk prediction for pulmonary arterial hypertension
por: Quan, Ruilin, et al.
Publicado: (2022) -
Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)